7 hours Ago
BridgeBio Pharma ( NASDAQ: BBIO ) is scheduled to announce Q1 earnings results on Tuesday, April 29th, after market close. The consensus EPS Estimate is -$1.00 and the consensus Revenue Estimate is $57.
72M (-72.7% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward.
Revenue estimates have seen 5 upward revisions and 1 downward. More on BridgeBio Pharma BridgeBio: Early Signs Point To Blockbuster Revenues BridgeBio: Strong Start For Attruby.
